FDA on Pathway's Class I Spit Kit Determination: 'Registration is Not Classification'
October 05, 2011
FDA on Pathway's Class I Spit Kit Determination: 'Registration is Not Classification'
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter - Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter - Pathway's Class I Determination for Collection Kit May Conflict with FDA Regulations
September 30, 2011 / GenomeWeb Daily News - FDA Okays First Genetic Test for Chronic Lymphocytic Leukemia Prognosis
August 24, 2011 / Pharmacogenomics Reporter